MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes
The new treatment option is administered once weekly, potentially reducing the number of injections from up to 365 a year to 52 for some adults with type 2 diabetes.
Cancele cuando quiera · 99 CA$/mes


